“…Children with Salmonella infections, particularly invasive infections, are commonly treated with expandedspectrum cephalosporins (eg, ceftriaxone) because of their favorable pharmacokinetic properties and low prevalence of resistance. [5][6][7][8] A limited number of cases of ceftriaxone-resistant Salmonella have been reported from South America, North Africa, Asia, Europe (France, Spain, Turkey, Greece, Hungary, United Kingdom, and Russia), and the United States. [9][10][11][12][13][14][15][16] A national survey of 10% of culture-confirmed Salmonella infections in 1995 found 3 of 4003 isolates resistant to ceftriaxone; each of these infections was acquired outside the United States.…”